Welcome, visitor! [ Login

Dragon Acquires Co-development Rights for Thrombopoietin


Dragon Pharmaceuticals Inc. is pleased to announce that Nanjing Huaxin Biotech Co., Ltd. has acquired co-development rights to a Pichia yeast culture system for the production of TPO from Kelong Industrial Co., Ltd, a Chinese company.

Dragon holds a 75% equity interest in Nanjing Huaxin. TPO is a blood growth factor that stimulates the production of platelets that are required in the process of haemostasis (i.e. blood coagulation), which is a critical process in blood clotting and wound healing.

Amgen and Genentech are developing TPO in North America, with Amgen using an E. coli bacterial system (and then modifying the protein for human use using PEG technology) and Genentech using a CHO cell culture. The Genentech technology was sold to Pharmacia-Upjohn, where it has entered Phase III clinical trials.

Huaxin has developed a Pichia yeast system which is expected to have a higher yield than the mammalian CHO cell line. Pre-clinical and animal studies that are required in China for permission to start human clinical trials have been completed. Since a yeast culture system for TPO has not been utilized anywhere in the world, Dragon’s TPO could be categorized as a Class I new drug in China by the State Bureau of Drug Administration. If a new drug license is granted, Dragon will enjoy exclusive marketing rights on TPO produced from a yeast culture system for 15 years in China. The Company plans to utilize its existing production facilities at Nanjing Huaxin and anticipates that its TPO product could be ready for marketing within two years.

Dragon Pharmaceuticals, the largest EPO producer in China, is currently a leading biotech company focusing on the research, development, production, and marketing of biodrugs throughout China.

Legal Dragon Pharma

Dragon Pharma is specialized in the manufacturing of high quality steroid gear TriTren 150 for Sale.

No Tags

1482 total views, 1 today


  • Dragon Ships EPO Internationally

    Dragon Pharmaceuticals Inc. (NASDAQ OTC: DRUG) today announced that it has filled orders for recombinant erythropoietin (EPO) from Egypt, India and Peru where, in addition to China, the Company’s EPO is approved for use in the treatment of anemia related to chronic renal failure. All dollar amounts are stated in US dollars. “Penetrating new markets […]

  • Dragon Pharmaceutical Inc. Announces 2002 Fourth Quarter and Full Year Results

    Dragon Pharmaceutical Inc. (TSX: DDD; OTC BB: DRUG) today announced results for the three-month and twelve-month periods ending December 31, 2002. 2002 Highlights Generated revenues of $7.36 million, representing significant growth from $3.07 million in 2001. Enhancement of gross margin in 2002 to 86.7% from 81% in 2001. Reported a first ever operating profit of […]

  • Dragon Announces Participation at Biopartnering Europe 2001

    Dragon Pharmaceuticals Inc. (OTC BB – DRUG.OB) is pleased to announce that it has been invited to present at the BioPartnering Europe 2001 conference to be held at the Queen Elizabeth II Conference Centre in London, England from October 14th to 16th, 2001. BioPartnering Europe is the premier European venue for showcasing innovative biopharmaceutical and […]

  • Dragon Launches EPO Into the Brazilian Market

    Dragon Pharmaceuticals Inc. (OTC BB: DRUG; TSX: DDD) today announced that it has shipped an order of recombinant erythropoietin (“EPO? to Itaca Laboratorios Ltda., (“Itaca” of Brazil. Itaca, a distribution partner of the company, has won a 3.1 million Brazilian Real tender for Dragon’s EPO in the Brazilian state of Minas, Gerais, which converts to […]

  • Dragon Signs Licensing Agreement for Korea

    Dragon Pharmaceuticals Inc. (OTCBB – DRUG.OB) today announced that it has entered into a marketing and licensing agreement with Boryung Biopharma Company, Ltd. of Seoul, Korea for the distribution of recombinant Erythropoietin (EPO) in North and South Korea. According to the agreement, Boryung Biopharma will also be responsible for obtaining marketing for EPO from the […]

Dragon Pharma Suppliers

dragon pharma source
american steroids online
real dragon pharma supplier
dragon pharma for sale
dragon pharma legit supplier
buy dragon pharma
dragon pharma store
buy steroids
dragon pharma legit dragon pharma anabolics